We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

237 hedge funds and large institutions have $6.73B invested in Alnylam Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 59 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 22

80% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 59

33% more call options, than puts

Call options by funds: $84.9M | Put options by funds: $63.7M

20% more funds holding in top 10

Funds holding in top 10: 10 → 12 (+2)

20% more capital invested

Capital invested by funds: $5.62B → $6.73B (+$1.11B)

10% more funds holding

Funds holding: 215 → 237 (+22)

Holders
237
Holders Change
+22
Holders Change %
+10.23%
% of All Funds
6.32%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.32%
New
47
Increased
106
Reduced
59
Closed
22
Calls
$84.9M
Puts
$63.7M
Net Calls
+$21.2M
Net Calls Change
+$5.1M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$151M
2
Capital World Investors
Capital World Investors
California
+$119M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$104M
4
Artisan Partners
Artisan Partners
Wisconsin
+$80.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$61.5M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$103M
2
AWG
Alpha Wave Global
New York
-$50.3M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$20.5M
4
EA
Emerald Advisers
Pennsylvania
-$20.2M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
126
Royal Bank of Canada
Ontario, Canada
$1.82M +$975K +9,619 +123%
Capital Fund Management (CFM)
127
Capital Fund Management (CFM)
France
$1.69M +$1.64M +16,171 New
IRF
128
IBM Retirement Fund
New York
$1.64M – – –
PP
129
Paloma Partners
Connecticut
$1.61M +$1.56M +15,384 New
LWCFA
130
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$1.58M -$107K -1,055 -7%
TD Asset Management
131
TD Asset Management
Ontario, Canada
$1.57M – – –
Comerica Bank
132
Comerica Bank
Texas
$1.43M -$1.38M -13,656 -50%
KFS
133
Kurt F. Somerville
$1.4M +$10.6K +105 +0.8%
URS
134
Utah Retirement Systems
Utah
$1.35M +$142K +1,400 +12%
Schroder Investment Management Group
135
Schroder Investment Management Group
United Kingdom
$1.29M – – –
HTHT
136
Hemenway Trust Hemenway Trust
New Hampshire
$1.27M +$6.08K +60 +0.5%
BF
137
BOK Financial
Oklahoma
$1.26M +$1.22M +12,051 New
VKH
138
Virtu KCG Holdings
New York
$1.25M +$1.22M +12,009 New
BBA
139
Baker Bros. Advisors
New York
$1.18M -$26.3K -260 -2%
ACH
140
ArrowMark Colorado Holdings
Colorado
$1.18M -$16.1M -159,092 -93%
EVM
141
Eaton Vance Management
Massachusetts
$1.09M +$7.6K +75 +0.7%
M&T Bank
142
M&T Bank
New York
$1.03M -$1.32K -13 -0.1%
SCM
143
Sterling Capital Management
North Carolina
$996K +$967K +9,539 New
SWK
144
Stephen W. Kidder
$948K – – –
Barclays
145
Barclays
United Kingdom
$922K +$845K +8,339 +1,579%
LPL Financial
146
LPL Financial
California
$902K +$56.7K +560 +7%
PCM
147
Prelude Capital Management
New York
$848K +$492K +4,855 +149%
Jane Street
148
Jane Street
New York
$838K +$814K +8,029 New
EIM
149
Essex Investment Management
Massachusetts
$817K +$387K +3,816 +95%
MAA
150
Managed Account Advisors
New Jersey
$806K -$163K -1,612 -17%
4 5
6
7 8

ALNY Hedge Fund Activity: Q1 2015 in Review

237 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2015, worth a combined $6.73B — up 20% from $5.62B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 22 closed out — a net gain of 25 holders — while 106 added to existing stakes and 59 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $151M. The largest seller was Franklin Resources, cutting an estimated $103M.

  • 237 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2015, up from 215 in Q4 2014.
  • Funds reported $6.73B of Alnylam Pharmaceuticals stock for Q1 2015, up 20% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2015 and 22 closed out, a net change of +25 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2015 was Wellington Management Group, an estimated $151M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2015 was Franklin Resources, an estimated $103M sold.

Based on aggregated 13F filings for Q1 2015.